Monthly Archives: January 2022

Ensuring Optimal Medication Adherence Monitoring

Considerations for Ensuring Optimal Digital Adherence Monitoring

It’s no secret, recruiting clinical trial participants is difficult, time-consuming, and considerably expensive, all while dropout rates are notoriously high across therapeutic areas. Whatever the motive for dropout, the impact is huge. Trials can become underpowered and may not have … Read More

Mitigating the Risk of Trial Failure with Digital Adherence Monitoring

Drug development is inherently risky, with some analysis showing that just 13.8% of products that enter industry-sponsored Phase I trials go on to obtain FDA approval.1 Of course, the exact figure varies across therapy areas and development stages, but it is … Read More

Adherence in Decentralized Clinical Trials

Addressing Medication Adherence in Decentralized Clinical Trials

Adherence monitoring can minimize variability and maximize engagement in DCTs Decentralized clinical trials (DCT) are growing in popularity, thanks to their ability to tear down many of the long-standing barriers to robust medical research. And while this new model has … Read More

Improving Clinical Trial ROI with Medication Adherence Management

Study power is the Holy Grail of clinical trials, setting drug developers on the quickest path to market – but non-adherence causes costly detours. When participants do not take their medication as specified in the study protocol, it can result … Read More